Page last updated: 2024-09-05

dabigatran and azd 0837

dabigatran has been researched along with azd 0837 in 3 studies

Compound Research Comparison

Studies
(dabigatran)
Trials
(dabigatran)
Recent Studies (post-2010)
(dabigatran)
Studies
(azd 0837)
Trials
(azd 0837)
Recent Studies (post-2010) (azd 0837)
3,8872613,49019715

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eikelboom, JW; Eriksson, BI; Quinlan, DJ1
Artang, R; Nielsen, JD; Rome, E; Vidaillet, HJ1
Cordova, EG; del Aguila, D; Salazar, CA1

Reviews

3 review(s) available for dabigatran and azd 0837

ArticleYear
Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism.
    Annual review of medicine, 2011, Volume: 62

    Topics: Acute Coronary Syndrome; Amidines; Anticoagulants; Atrial Fibrillation; Azetidines; Benzimidazoles; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thrombin; Thromboembolism; Treatment Outcome; Vitamin K

2011
Meta-analysis of randomized controlled trials on risk of myocardial infarction from the use of oral direct thrombin inhibitors.
    The American journal of cardiology, 2013, Dec-15, Volume: 112, Issue:12

    Topics: Amidines; Anticoagulants; Antithrombins; Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; beta-Alanine; Dabigatran; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Warfarin

2013
Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation.
    The Cochrane database of systematic reviews, 2014, Mar-27, Issue:3

    Topics: Amidines; Antithrombins; Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; beta-Alanine; Dabigatran; Drug Administration Schedule; Embolism; Female; Humans; Male; Randomized Controlled Trials as Topic; Safety-Based Drug Withdrawals; Stroke; Vitamin K; Warfarin

2014